Advancing Sustainable Implementation of Comprehensive HIV Prevention and Treatment Programs in Faith-based and Private Sites in Nairobi, Coast and Western Regions in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PE | CDC RFA GH22 2209

Opportunity Information: Apply for CDC RFA GH22 2209

This funding opportunity is a CDC cooperative agreement under PEPFAR focused on strengthening and sustaining comprehensive HIV prevention, care, and treatment services delivered through private and faith-based health facilities in Kenya. It is designed to support high-quality HIV programming in three priority geographic areas and partner networks: Eastern Deanery AIDS Relief Program-affiliated sites serving the eastern slums of Nairobi County, Coptic Hospital-affiliated sites in Nairobi and Vihiga Counties, and Bomu Hospital-affiliated sites across Mombasa, Kwale, and Kilifi Counties along the Coast. The overarching aim is to expand coverage and improve quality of HIV services while embedding those services into routine health care delivery so that county health systems and local communities increasingly own, finance, and sustain the work over time.

The CDC anticipates a total funding amount of about USD 29,136,875 for the first year, contingent on the availability of funds, with an expectation of up to five awards. Although an award ceiling is listed as zero for Year 1 (meaning no maximum cap is specified in the notice), the overall projected first-year total gives a sense of the scale. The opportunity is open to unrestricted applicants, meaning a broad range of organizations may apply, subject to any eligibility clarifications in the full notice. The mechanism is a cooperative agreement, which typically indicates substantial involvement by CDC in technical direction, collaboration, and oversight during implementation rather than a hands-off grant.

Programmatically, the award supports a full continuum of HIV services, with an emphasis on integration and efficiency. Core components include HIV testing services (HTS) to identify people living with HIV and link them quickly to care; pediatric and adult HIV treatment to improve viral suppression and long-term health outcomes; and TB/HIV integrated services covering prevention, diagnosis, and treatment because tuberculosis remains a major cause of illness and death among people living with HIV. It also includes prevention of mother-to-child transmission (PMTCT) to protect infants and move toward elimination of mother-to-child transmission (eMTCT), as well as voluntary medical male circumcision (VMMC) as an evidence-based prevention intervention in appropriate populations and settings.

Beyond clinical services, the opportunity emphasizes differentiated approaches for groups with elevated risk or unique barriers to care. This includes programming for orphans and vulnerable children (OVC), recognizing that HIV affects household stability, child wellbeing, and access to services. It also specifically calls out key population (KP) services for female sex workers, men who have sex with men, transgender people, and people who inject drugs, reflecting the need for tailored, stigma-aware prevention and treatment models that improve access, retention, and outcomes. In addition, it includes HIV prevention programming for adolescent girls and young women (AGYW), a group often disproportionately affected by new infections in many settings, with prevention approaches that are typically linked to broader sexual and reproductive health services and community-based risk reduction.

The notice also highlights the importance of supporting laboratory services and strategic information. In practice, this usually means strengthening lab networks and quality systems needed for HIV diagnosis and monitoring (such as viral load testing), as well as improving data systems, surveillance, reporting, and use of data for program improvement. Strong strategic information is essential for tracking progress along the HIV care cascade (testing, linkage, treatment initiation, retention, viral suppression) and for targeting prevention resources to where they will have the greatest impact.

In terms of expected results, the opportunity is framed around improving both coverage and quality across all populations served by the supported private and faith-based sites. The intended outcomes are fewer new HIV infections (reduced incidence), lower illness and death among people living with HIV (reduced morbidity and mortality), and progress toward eliminating mother-to-child transmission. The work is explicitly aligned with UNAIDS, PEPFAR, and the Government of Kenya goals of ending AIDS as a public health threat by 2030, and it reflects a sustainability-oriented approach in which HIV services are not run as standalone projects but are integrated into routine service delivery with stronger county and community linkages to promote long-term ownership and financing.

Key administrative details include the funding opportunity number CDC RFA GH22 2209, CFDA 93.067, and the original application closing date of February 22, 2022, with electronic submissions due by 11:59 pm Eastern Time on the deadline date listed in the notice.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Advancing Sustainable Implementation of Comprehensive HIV Prevention and Treatment Programs in Faith-based and Private Sites in Nairobi, Coast and Western Regions in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PE" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Dec 22, 2021.
• Applicants must submit their applications by Feb 22, 2022 Electronically submitted applications must be submitted no later than 1159 pm ET on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for CDC RFA GH22 2209

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: